# Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients

> **NCT01068067** · NA · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 60 (estimated)

## Conditions studied

- Renal Transplantation

## Interventions

- **OTHER:** drug (tacrolimus and SchE) and genetics
- **DRUG:** tacrolimus

## Key facts

- **NCT ID:** NCT01068067
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-03
- **Primary completion:** 2012-12
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2010-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01068067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01068067, "Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01068067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*